Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Huizinga

Showing results (101-110 of 152) with videos related to

Pageof 16
Sort By:
RMD Open|November 5, 2015
Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 studyMichael Schiff, Bernard Combe, Thomas Dörner, et al.
Genes and Immunity|November 13, 2001
Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosusM W van der Linden, A R van der Slik, E Zanelli, et al.
British Journal of Haematology|July 1, 1992
Further characterization of the NB 1 antigen as a variably expressed 56-62 kD GPI-linked glycoprotein of plasma membranes and specific granules of neutrophilsR Goldschmeding, C M van Dalen, N Faber, et al.
Human Gene Therapy|May 26, 1999
Feasibility of adenovirus-mediated nonsurgical synovectomy in collagen-induced arthritis-affected rhesus monkeysP H Goossens, G J Schouten, B A 't Hart, et al.
British Journal of Rheumatology|May 1, 1997
Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease?B M Brinkman, T W Huizinga, S S Kurban, et al.
Pharmacogenomics|April 1, 2015
FcGR genetic polymorphisms and the response to adalimumab in patients with rheumatoid arthritisCristina Lucía Dávila-Fajardo, Tahar van der Straaten, Rene Baak-Pablo, et al.
Immunogenetics|November 3, 1998
An extended HLA-DQ-DR haplotype rather than DRB1 alone contributes to RA predispositionE Zanelli, T W Huizinga, P A Guerne, et al.
Current Medical Research and Opinion|February 20, 2019
Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studiesJeffrey R Curtis, Cecilie H Brahe, Mikkel Østergaard, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 3, 2010
Perfusion MRI in neuro-psychiatric systemic lupus erthemathosusBart J Emmer, Matthias J van Osch, Ona Wu, et al.
Annals of Neurology|October 12, 2000
Innate production of interleukin-10 and tumor necrosis factor affects the risk of multiple sclerosisB A de Jong, H M Schrijver, T W Huizinga, et al.
Pageof 16

Showing results (101-110 of 152) with videos related to

Sort By:
Pageof 16
RMD Open|November 5, 2015
Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 studyMichael Schiff, Bernard Combe, Thomas Dörner, et al.
Genes and Immunity|November 13, 2001
Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosusM W van der Linden, A R van der Slik, E Zanelli, et al.
British Journal of Haematology|July 1, 1992
Further characterization of the NB 1 antigen as a variably expressed 56-62 kD GPI-linked glycoprotein of plasma membranes and specific granules of neutrophilsR Goldschmeding, C M van Dalen, N Faber, et al.
Human Gene Therapy|May 26, 1999
Feasibility of adenovirus-mediated nonsurgical synovectomy in collagen-induced arthritis-affected rhesus monkeysP H Goossens, G J Schouten, B A 't Hart, et al.
British Journal of Rheumatology|May 1, 1997
Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease?B M Brinkman, T W Huizinga, S S Kurban, et al.
Pharmacogenomics|April 1, 2015
FcGR genetic polymorphisms and the response to adalimumab in patients with rheumatoid arthritisCristina Lucía Dávila-Fajardo, Tahar van der Straaten, Rene Baak-Pablo, et al.
Immunogenetics|November 3, 1998
An extended HLA-DQ-DR haplotype rather than DRB1 alone contributes to RA predispositionE Zanelli, T W Huizinga, P A Guerne, et al.
Current Medical Research and Opinion|February 20, 2019
Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studiesJeffrey R Curtis, Cecilie H Brahe, Mikkel Østergaard, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 3, 2010
Perfusion MRI in neuro-psychiatric systemic lupus erthemathosusBart J Emmer, Matthias J van Osch, Ona Wu, et al.
Annals of Neurology|October 12, 2000
Innate production of interleukin-10 and tumor necrosis factor affects the risk of multiple sclerosisB A de Jong, H M Schrijver, T W Huizinga, et al.
Pageof 16